Celldex Therapeutics, Inc. (CLDX)
23.44
-1.16
(-4.72%)
USD |
NASDAQ |
Feb 12, 16:00
23.41
-0.03
(-0.13%)
After-Hours: 20:00
Celldex Therapeutics EPS Diluted (Quarterly) : -1.009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
| Kiora Pharmaceuticals, Inc. | 0.0062 |
| Intellia Therapeutics, Inc. | -0.9196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.04M |
| Total Expenses (Quarterly) | 67.04M |
| Enterprise Value | 1.060B |
| Earnings Yield | -14.43% |
| Normalized Earnings Yield | -14.43 |